Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Lupus Erythematosus, Systemic 1Infectious Mononucleosis 1Infections 1Fatigue Syndrome, Chronic 1Epstein-Barr Virus Infections 1

Interventions

Rituximab 7Valganciclovir 5Valacyclovir 3Gemcitabine 3Dexamethasone 3Cisplatin 3spartalizumab 2pegaspargase 2Radiotherapy, Intensity-Modulated 2Methylprednisolone 2Lenalidomide 2Etoposide 2Doxorubicin 2Cell Count 2Blood Specimen Collection 2valomaciclovir 1toripalimab 1ruxolitinib 1pembrolizumab 1merphos 1fludarabine 1dehydroftorafur 1avelumab 1apatinib 1Zidovudine 1Watchful Waiting 1Valproic Acid 1Vaccines 1Tenofovir 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Epstein-Barr Virus Infections × Procalcitonin × Clear all
NCT05127980 2025-02-25

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

University Hospital, Basel, Switzerland

Recruiting
80 enrolled

Infections, Infectious Mononucleosis, Lupus Erythematosus, Systemic, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡